Delayed Release Tablet Dosage Form

Known as: Tablet, delayed release, Delayed Release Tablet Dose Form, TAB DR 
A tablet that has been coated with a substance that is designed to impede the immediate release of the active and/or inert ingredient(s) after… (More)
National Institutes of Health

Related topics

Related topics

3 relations
CDISC SDTM Pharmaceutical Dosage Form TerminologyClinical Data Interchange Standards Consortium TerminologyStructured Product Labeling Pharmaceutical Dosage Form Terminology

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Development and in vitro characterization of mebendazole delayed release tablet for colonic drug delivery.
The main objective behind this study was to formulate delayed release colon targeted tablet of Mebendazole by using different… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • table 3
Is this relevant?
2014
2014
Panax notoginseng saponins pulse delayed release tablet and new application thereof in pharmacy
 
Is this relevant?
2013
2013
Formulation and evaluation of enteric coated tablet of Ilaprazole
The present study was an attempt to formulate and evaluate enteric coated tablets for Ilaprazole to reduce the gastrointestin al… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
2012
2012
FORMULATION AND EVALUATION OF ESOMEPRAZOLE DELAYED RELEASE TABLETS
  • TUSHAR G. RUKARI, GANESH V. AHIRE
  • 2012
In the present work emphasize on Esomeprazole magnesium is formulated as delayed release tablets to provide desired effect at… (More)
  • figure 1
  • table 2
  • table 1
  • table 5
  • table 6
Is this relevant?
2012
2012
Azulfidine EN-tabs® sulfasalazine delayed release tablets, USP Enteric-coated Tablets DESCRIPTION AZULFIDINE EN-tabs Tablets contain sulfasalazine, formulated in a delayed release tablet (enteric…
  • 2012
CLINICAL PHARMACOLOGY Pharmacodynamics The mode of action of sulfasalazine (SSZ) or its metabolites, 5-aminosalicylic acid (5… (More)
Is this relevant?
2012
2012
DESIGN, IN VITRO EVALUATION AND IN VIVO STUDIES OF NOVEL DELAYED RELEASE TABLETS OF PANTOPRAZOLE
In an effort to reduce production costs, a simple, direct compression delayed release formulation consisting of pantoprazole was… (More)
  • figure 1
  • figure 2
  • figure 4
  • table 1
  • table 2
Is this relevant?
2011
2011
Oral dispersible delayed release tablet formulation
 
Is this relevant?
2007
2007
Pharmacokinetics of the CYP 3A Substrate Simvastatin following Administration of Delayed Versus Immediate Release Oral Dosage Forms
The study was designed to evaluate the effect of delayed release (DR) on absorption and bioavailability of intestinally… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table I
Is this relevant?
2007
2007
LIALDATM (mesalamine) Delayed Release Tablets DESCRIPTION Each LIALDA delayed release tablet for oral administration contains 1.2g 5-aminosalicylic acid (5-ASA; mesalamine), an anti-inflammatory…
  • LIALDA 1.2g
  • 2007
The mechanism of action of mesalamine is not fully understood, but appears to be topical. Mucosal production of arachidonic acid… (More)
  • table 1
  • table 2
  • table 3
Is this relevant?
2001
2001
Bioavailability and stability of erythromycin delayed release tablets.
BACKGROUND Erythromycin is available as the free base, ethylsuccinate, estolate, stearate, gluceptate, and lactobionate… (More)
  • figure 1
  • figure 4
  • table 1
Is this relevant?